Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Gleason

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
JAMA|March 15, 1976
Letter: Ambulatory medical care recordsM C Gleason
Plastic and Reconstructive Surgery|August 1, 1973
Brow lifting through a temporal scalp approachM C Gleason
Plastic and Reconstructive Surgery|December 1, 1970
Xeroderma pigmentosum--five-year arrest after total resurfacing of the faceM C Gleason
Plastic and Reconstructive Surgery|October 1, 1996
Supposed parotid fistula following rhytidectomyM C Gleason
Blood|March 15, 1997
Selection for drug resistance results in resistance to Fas-mediated apoptosisT H Landowski, M C Gleason-Guzman, W S Dalton
International Journal of Cancer|May 16, 1996
Resistance to the chemosensitizer verapamil in a multi-drug-resistant (MDR) human multiple myeloma cell lineM R Abbaszadegan, N E Foley, M C Gleason-Guzman, et al.
The Journal of Allergy and Clinical Immunology|October 1, 1992
High-dose systemic glucocorticoid therapy in the treatment of severe asthma: a case of resistance and patterns of responseA K Kamada, D Y Leung, M C Gleason, et al.
Cancer Research|February 1, 1991
Development and characterization of a melphalan-resistant human multiple myeloma cell lineW T Bellamy, W S Dalton, M C Gleason, et al.
International Journal of Cancer|May 16, 1996
Verapamil suppresses the emergence of P-glycoprotein-mediated multi-drug resistanceB W Futscher, N E Foley, M C Gleason-Guzman, et al.
Cancer Research|November 15, 1988
Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damageW T Bellamy, W S Dalton, J M Kailey, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
JAMA|March 15, 1976
Letter: Ambulatory medical care recordsM C Gleason
Plastic and Reconstructive Surgery|August 1, 1973
Brow lifting through a temporal scalp approachM C Gleason
Plastic and Reconstructive Surgery|December 1, 1970
Xeroderma pigmentosum--five-year arrest after total resurfacing of the faceM C Gleason
Plastic and Reconstructive Surgery|October 1, 1996
Supposed parotid fistula following rhytidectomyM C Gleason
Blood|March 15, 1997
Selection for drug resistance results in resistance to Fas-mediated apoptosisT H Landowski, M C Gleason-Guzman, W S Dalton
International Journal of Cancer|May 16, 1996
Resistance to the chemosensitizer verapamil in a multi-drug-resistant (MDR) human multiple myeloma cell lineM R Abbaszadegan, N E Foley, M C Gleason-Guzman, et al.
The Journal of Allergy and Clinical Immunology|October 1, 1992
High-dose systemic glucocorticoid therapy in the treatment of severe asthma: a case of resistance and patterns of responseA K Kamada, D Y Leung, M C Gleason, et al.
Cancer Research|February 1, 1991
Development and characterization of a melphalan-resistant human multiple myeloma cell lineW T Bellamy, W S Dalton, M C Gleason, et al.
International Journal of Cancer|May 16, 1996
Verapamil suppresses the emergence of P-glycoprotein-mediated multi-drug resistanceB W Futscher, N E Foley, M C Gleason-Guzman, et al.
Cancer Research|November 15, 1988
Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damageW T Bellamy, W S Dalton, J M Kailey, et al.
Pageof 2